Statistics for Chemomab Therapeutics Ltd. (id:6392 CMMB)
Valuation metrics
Market cap
31.87M
Enterprise value
447.13M
Trailing P/E (ttm)
3.00
Forward P/E
-42.25
PEG ratio
-42.25
Price/Sales (ttm)
Price/Book (mrq)
1.41
Enterprise Value/Revenue
Enterprise Value/EBITDA
-28.00
Overview
Shares outstanding
18.86M
Float
169.53M
Shares short
162.90K
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
76.13K
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
2.55
52-Week change
69.06%
Beta
3.00
50-Day moving average
1.53
200-Day moving average
1.18
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
March 17, 2021
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-46.18%
Return on equity
-93.80%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-15,969,000.00
Net income to common (ttm)
-14,997,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
12.73M
Total cash per share (mrq)
5.00
Total debt (mrq)
360.00K
Total Debt/Equity (mrq)
3.60
Current ratio (mrq)
312.30%
Book value per share (mrq)
1.20
Cash flow
Cash flow statement
-16,130,000.00
Levered free cash flow (LFCF)
-11,364,375.00